ã¡ãã£ã¢èšäº
ããããã¯ã¹è£œã¯ã¯ãã³äŸçµŠå¥çŽã1å5åäžååã22幎ãã
ããºãææ°ããŒã¯ 2,573
twitterã³ã¡ã³ã 505ä»¶äž 301ïœ400件
éžæè¢ãå¢ããã®ã¯ããã§ãããmRNAã¯ã¯ãã³ãããªããšãªãå«ããªãããã®äººã«ã¯ä»£æ¿æ¡ã«ãªãããã§ããããã
-
-
ã¯ã¯ã¯ã¯èšã£ãŠããã©ããæ²»çè¬ã§è¯ããªãïŒãªãã§ãããªã«ã¯ã¯æã¡ãããã®ãè¬ãäžèœè¬ããŸãã¯é·å¯¿ã®è¬ã ãšã§ãæã£ãŠãã®ããªïŒ
éºäŒåã¯ã¯ãã³ãããªããã°ããæã€ãã
å°å
ãæ¥çš®ã§ãããšãããªã
ããïŒæŠç°ãåœå
çç£ããåã¯ïŒïŒ
ç±³ããããã¯ã¹ç€Ÿè£œã¯ã¯ãã³å¥çŽãç· çµã2022幎åé ãã1.5åååäŸçµŠãæŠç°è£œåå·¥æ¥ãåœå
ã§çç£ã»æµéãè¡ãã
ã®ãããããããªãð€ð€
è±äŒè©±ã ãã§ãªãã¯ã¯ãã³ã«ãåå ¥ããâŠw
è±äŒè©±ã ãã§ãªãã¯ã¯ãã³ã«ãåå ¥ããâŠw
mRNAãããªããŠæ¢åã®ã¿ã€ãã®ã¯ã¯ãã³ã£ãŠããšããªïŒã¯ã¯ãã³ã€ã€ã€ã€å¢ã®äžéšãåã蟌ãäœæŠããªãmRNAããæã£ã人ã«ã¯ã©ãå¹æãããããã
åœå
補é ã§ããŠæŠç°è¬åå·¥æ¥ããå®å®äŸçµŠããããšè¯ããã
â§ïŒ¿â§
( Ï)ïŒã€â¡ã€
(㣠â¡ã€ïŒã€
/ ) ïŸ ïŸïŸïŸïŸïœ¯
( /ï¿£âª
( Ï)ïŒã€â¡ã€
(㣠â¡ã€ïŒã€
/ ) ïŸ ïŸïŸïŸïŸïœ¯
( /ï¿£âª
æ©ããã°2022幎åé ããã (Ï)
ååŽçã¯7æ¥ãç±³ããããã¯ã¹è£œã®ã¯ã¯ãã³ã«ã€ããŠãæ©ããã°2022幎åé ãã1å5åäžååã®äŸçµŠãåããå¥çŽããåœå ã§çç£ãæµéãæ ãæŠç°è¬åå·¥æ¥ãšã®éã§ç· çµãšçºè¡šã
ååŽçã¯7æ¥ãç±³ããããã¯ã¹è£œã®ã¯ã¯ãã³ã«ã€ããŠãæ©ããã°2022幎åé ãã1å5åäžååã®äŸçµŠãåããå¥çŽããåœå ã§çç£ãæµéãæ ãæŠç°è¬åå·¥æ¥ãšã®éã§ç· çµãšçºè¡šã
ååããããã
åå䌌ãŠãŠã¡ãã£ãšçŽãããããªã
ãããã¯ã¹ã®ã¯ã¯ãã³èªå¯ïŒ
å æ°æã®æ ªãè²·ããªããðŠ
å æ°æã®æ ªãè²·ããªããðŠ
ããããšãã£ãŠãã
æ¿æš©äº€ä»£ããããããäžé²ã¯ã¯ãã³ãå ¥ã£ãŠããã®ããªïŒ
ãªããŠãã
æ¿æš©äº€ä»£ããããããäžé²ã¯ã¯ãã³ãå ¥ã£ãŠããã®ããªïŒ
ãªããŠãã
3åç®ã4åç®çšã®ã¯ã¯ãã³ããªïŒ
æ¬åœã«ãããããŸãã ãŒ
æ¬åœã«ãããããŸãã ãŒ
ã¢ãã«ããã¢ã¡ãªã«è£œã§ãããïŒ
ã¯ã¯ãã³ã§ã¢ã¡ãªã«ã¯ç©ºåã®å©çãåºãã®ã§ã¯ïŒïŒ
ã¯ã¯ãã³ã§ã¢ã¡ãªã«ã¯ç©ºåã®å©çãåºãã®ã§ã¯ïŒïŒ
å¡©é矩ãéçºããŠããçµã¿æ¿ãããã±ãã¯ã¯ãã³ã§ãããããããã¯ã¹ãå
è¡ããŠããŸãã
以åãã䜿ãããŠãæè¡ãªã®ã§ãå®çžŸããããçŸã¯ã¯ãã³ãæ¥çš®ã§ããªãæ¹ãæ¥çš®ã§ããã®ã§ã¯ïŒ
以åãã䜿ãããŠãæè¡ãªã®ã§ãå®çžŸããããçŸã¯ã¯ãã³ãæ¥çš®ã§ããªãæ¹ãæ¥çš®ã§ããã®ã§ã¯ïŒ
ããããã¯ã¹ããã¿ãð
ã§ããããã¯ãã¡ã€ã¶ãŒããã¢ãã«ãåŸã«æ¥çš®ããŠã倧äžå€«ãªã®ïŒ
ã§ããããã¯ãã¡ã€ã¶ãŒããã¢ãã«ãåŸã«æ¥çš®ããŠã倧äžå€«ãªã®ïŒ
å€åœãšã®å¥çŽãè¯ããã©ããããªæäœã¯çšéã§è£œè¬äŒç€Ÿã倧åŠã®ç 究宀ã«å€é¡ã®è£å©éåºããŠãããã°è¯ãã®ã«
ãŸããè®è«ã®äºæ¥ä»åãã®ãŸãŸããã幞ããšæŸçœ®ããŠãããããªãã ãããªïŒ
ãŸããè®è«ã®äºæ¥ä»åãã®ãŸãŸããã幞ããšæŸçœ®ããŠãããããªãã ãããªïŒ
m-RNAãããªãã¯ã¯ãã³ãå»è
ãæ¿åºããã¹ã³ãã«ç
œãããŠã¯ã¯ãã³ã¯m-RNAãããªãããã«æŽè³ãããŠãããã©ããããã·ãªãã®ã®ã¯ã¯ãã³ãæã¡ãã
ãã¯ãæ¥çš®3åç®ã¯ãã£ã¡ã«ãªãã®ããã
æŠç°è£œè¬ã¯ã¢ãã«ããšä»åã¯ããããã¯ã¹ãæ±ãã
èªç€Ÿã§éçºãããïŒ
ãã·ã¥è²·åãããã§éçºããéãç¡ãã®ãïŒ
ãã¯ã補è¬åµè¬æ¥ãããªã補è¬å瀟ã ã
èªç€Ÿã§éçºãããïŒ
ãã·ã¥è²·åãããã§éçºããéãç¡ãã®ãïŒ
ãã¯ã補è¬åµè¬æ¥ãããªã補è¬å瀟ã ã
ããïŒmRNAãããã®ïŒ
ã ããããããã¯ã¹æ¥ããŒãåŸæ¥åã®ã¯ã¯ãã³ãšããããšã¯ãmRNAåã«æ¯ã¹ããå¯åå¿ãç©ãããªã®ã ããããããã§ããã°ããŒã¹ã¿ãŒã¯ã¯ãã³ãšããŠãã䜿ããããããã
ãããŒïŒé 匵ããŒïŒ
Japan strike a 150mil doses deal with Takeda Phamaceutical on NVAX vaccine today!!!!
Japan strike a 150mil doses deal with Takeda Phamaceutical on NVAX vaccine today!!!!
æŠåšã¯å¢ããŠããŠãããªã
å®æã«ä¿ããªãç°¡åã«äžè«ããå¯ã£ãŠæ¥ãããå æé¢ä¿ã¯ç¡ãã£ãŠå§¿å¢ã«ãªã£ãŠããã ãã
æ°Žé¢äžã§å°å
¥æšé²ãããŠãã第4ã®ã¯ã¯ãã³
åœå çç£ã売ãã§ããããã®ã¯ã¯ãã³æ¥çš®ãããäž»æµã«ãªããã
åœå çç£ã売ãã§ããããã®ã¯ã¯ãã³æ¥çš®ãããäž»æµã«ãªããã
å®æã«ä¿ããªãç°¡åã«äžè«ããå¯ã£ãŠæ¥ãããå æé¢ä¿ã¯ç¡ãèšã£ãŠå§¿å¢ã«ãªã£ãŠããã ãã
ðŠéå©ïŒ
ð¿ïŸïŸïŸïŸïŸïœ°ïœ¯!!
ð¿ïŸïŸïŸïŸïŸïœ°ïœ¯!!
æŠç°ãŒ(>_<)(>_<)
ãžãŒã
2022幎åé ãã1å5åäžååã®äŸçµŠãåããå¥çŽããåœå
ã§çç£ãæµéãæ
ãæŠç°è¬åå·¥æ¥ãšã®éã§ç· çµ
mRNAæã人ã«ã¯æå ±ããª
mRNAæã人ã«ã¯æå ±ããª
çµã¿æ¿ãã¿ã³ãã¯ã¯ã¯ãã³ã ãããm RNAã¯ã¯ãã³ãšã»ãŒéè²ãªããããã®æ§èœãããæåŸ
ããŒã
åœç£ãŸã ã§ããð
åœç£ãŸã ã§ããð
ãããå
šç¶çµããããæ°ãªããã
ååã·ãããã¯ãšäŒŒãŠãããå€ããæ¹ããã
è
ç·çã®çœ®ãåç£ã§ãã
æ¬åœã®æå³ã§ä»äºäººã§ãããã
å¿ããæè¬ããŸãã
æ¬åœã®æå³ã§ä»äºäººã§ãããã
å¿ããæè¬ããŸãã
ã©ãæããŸãïŒ
ç§ã¯ã¢ãã«ããæ¥çš®ããŠäœãçµéšããŠå€§äžå€«ã ã£ãã®ã§ãïŒåç®ãã¢ãã«ãæã¡ããã
éãç©ãäœã«å ¥ããäžå®ã¹ãã¬ã¹ã¯å«ã ïŒ
ç§ã¯ã¢ãã«ããæ¥çš®ããŠäœãçµéšããŠå€§äžå€«ã ã£ãã®ã§ãïŒåç®ãã¢ãã«ãæã¡ããã
éãç©ãäœã«å ¥ããäžå®ã¹ãã¬ã¹ã¯å«ã ïŒ
æ¥æ¬ããéåœã«ã¯æž¡ããªãæ»è
ãã§ãã°ãŸã匷è«ãã»ã¿ã«ãªããããã
Modernaããã³ããã®æ¹ãè¯ãâŠã
å±éºããããæ¿èªã¯èªããªãã
3åç®ä»¥éã®äº€å·®æ¥çš®ã«ã€ããŠããããçå£ã«è°è«ããŠããã ãããã
ã¬ãŒã¹ãŒã®ã³ãã察çå°å¿µã¯å©æš©åé¡ã ã
éžæè¢ãå¢ããã®ã¯ããããšã ãã
ã€ã§ã€ïŒ
ãããæ¯å¹Žã«ãªãã®ãããð
ãïŒãã£ã€ããšæã£ããããã¯ã·ãããã¯ã
ãã¡ã€ã¶ãŒã§å¯åå¿çã«ïŒåç®ã¯âŠã£ãŠèšãããŠãã ãã«æåŸ ããããã©ãåœç£å«ããŠããå°ãæ©ãæãŠãªãããªð
ãã¡ã€ã¶ãŒã§å¯åå¿çã«ïŒåç®ã¯âŠã£ãŠèšãããŠãã ãã«æåŸ ããããã©ãåœç£å«ããŠããå°ãæ©ãæãŠãªãããªð
æå³äžæãªã¿ã€ãã³ã°ãå©æš©ã®èãããããæªããã
éžæè¢ãå¢ããŸããããŒãŒãŒã£ãšð€ª
ãããç°ç©æ··å ¥ã®æŠç°ã ãããããð©
ãããç°ç©æ··å ¥ã®æŠç°ã ãããããð©
次ã¯ããããããããããã¯ã¹ããã£ãŠæãïŒ
åŸæ¥åã¯ã¯ãã³ã®ããããã¯ã¹/æŠç°ã®ã¯ã¯ãã³
çš®é¡ã¯çµã¿æ¿ãã¿ã³ãã¯ã¯ã¯ãã³
åçåŽåçã¯7æ¥ãæ©ããã°2022幎åé ãã1å5åäžååã®äŸçµŠãåããå¥çŽãç· çµãšçºè¡š
è¿œå æ¥çš®ãžã®äœ¿çšãèŠéã«éçºãå€ç°æ ªãžã®å¯Ÿå¿ãæ³å®ãš
çš®é¡ã¯çµã¿æ¿ãã¿ã³ãã¯ã¯ã¯ãã³
åçåŽåçã¯7æ¥ãæ©ããã°2022幎åé ãã1å5åäžååã®äŸçµŠãåããå¥çŽãç· çµãšçºè¡š
è¿œå æ¥çš®ãžã®äœ¿çšãèŠéã«éçºãå€ç°æ ªãžã®å¯Ÿå¿ãæ³å®ãš
ãæ°åãŠã€ã«ã¹ã¯ã¯ãã³ã®æçµæ®µéã®èšåºè©Šéšã§ãïŒïŒïŒïŒïŒ
ã®æå¹æ§ã確èªã§ãããšçºè¡šããŸããããŸããéçåãé²ãå¹æã¯ïŒïŒïŒïŒ
ã
ãã¡ã€ã¶ãŒããä¹ãæãããã
ã¯ã¯ãã³æ¯å¹Žæ¥çš®ç¶ããªããšãããªãã®ããªã
ãã¡ã€ã¶ãŒããä¹ãæãããã
ã¯ã¯ãã³æ¯å¹Žæ¥çš®ç¶ããªããšãããªãã®ããªã
ç°ç©æ··å
¥ãªã¹ã¯é«
ãã£ãšã ãåŸ
ã£ãŠããã
ã¿ã³ãã¯ã¯ã¯ãã³ã
ã§ã4ã¶æã»ã©å ã ãããå€åæã€åã«ã³ããã£ã¡ãããªã
â
ã¿ã³ãã¯ã¯ã¯ãã³ã
ã§ã4ã¶æã»ã©å ã ãããå€åæã€åã«ã³ããã£ã¡ãããªã
â
ãžã§ã³ãœã³ã¢ã³ããžã§ã³ãœã³ã®ã¯ãã©ããã£ãïŒ
å€çš®é¡ã®ã¯ã¯ãã³ãæ¥æ¬ã«éãŸã£ãŠããŸããã
ãããã£ã¡ãæ£åŒã«ãã
䜿ãåæãè¯ãã¿ã€ãã ããå¯åå¿æ°ã«ããŠã人ã¯ãã£ã¡ãã£ãŠãªããããª
䜿ãåæãè¯ãã¿ã€ãã ããå¯åå¿æ°ã«ããŠã人ã¯ãã£ã¡ãã£ãŠãªããããª
çµã¿æ¿ãã¿ã³ãã¯ã¯ã¯ãã³ã®ãã®ããã_Ï(_
å€åœã«é Œãã ãã§ãªããèªåœã§å¯ŸåŠåºæ¥ãæ§ãåœç£ã¯ã¯ãã³ã®éçºãé²ããŠã»ããâ
ããããã¯ã¹ïŒïŒãªãã匷ãããªé¿ã
ãŸã ããð
ããããã¯ã¹è£œ1.5åååå¥çŽ
ãå¡©é矩ãã¯ã¯ãã³ïŒåäžäººå幎å ã«ãçç£äœå¶âæ°åã³ãããæäº
ãåœç£ãèªå·±å¢æ®åmRNAã¯ã¯ãã³ãã®èšåºè©Šéšèšç»ãæ¿èª 10æã®æ²»éšéå§ç®æããDCN
ãå¡©é矩ã®ã³ãã飲ã¿è¬ã幎å ã«100äžäººå以äžã®äŸçµŠäœå¶ãæ¥çµ
çºè¡šåã§ãæ¥æ¬ãããåªç§ã
ãå¡©é矩ãã¯ã¯ãã³ïŒåäžäººå幎å ã«ãçç£äœå¶âæ°åã³ãããæäº
ãåœç£ãèªå·±å¢æ®åmRNAã¯ã¯ãã³ãã®èšåºè©Šéšèšç»ãæ¿èª 10æã®æ²»éšéå§ç®æããDCN
ãå¡©é矩ã®ã³ãã飲ã¿è¬ã幎å ã«100äžäººå以äžã®äŸçµŠäœå¶ãæ¥çµ
çºè¡šåã§ãæ¥æ¬ãããåªç§ã
ããããã¯ã¹ãšã®å¥çŽãåããŠãã¯ã¯ãã³ã®ç¢ºä¿ã«é¢ããåçµããæŽæ°ãããŠããã
åœéåååŒã¯çããã®ã§ã¯ãªãã®ã§æ³šæããŠãã ããïŒ
ã£ãŠããã¡ã€ã¶ãŒã¢ãã«ããšåãããŠäººå£Ã4ååã¯ç¢ºä¿ããã£ãŠããšãã
ã°ããžã§ãã ãšæããŸã£ã
ã£ãŠããã¡ã€ã¶ãŒã¢ãã«ããšåãããŠäººå£Ã4ååã¯ç¢ºä¿ããã£ãŠããšãã
ã°ããžã§ãã ãšæããŸã£ã
ãã¡ã€ã¶ãŒã®ã¢ãã«ããšéãã¿ã€ãã§æå¹çãåçãããã
ãã ãã·ãããã¯ïŒäžåœè£œïŒãšååã䌌ãŠãããå°ãæ··ä¹±ãããã
ãã ãã·ãããã¯ïŒäžåœè£œïŒãšååã䌌ãŠãããå°ãæ··ä¹±ãããã
ããããããããããããã
mRNAãããªããŠåŸæ¥åã®ã¿ã³ãã¯è³ªçµã¿æãã¿ã€ã
mRNAãããªããŠåŸæ¥åã®ã¿ã³ãã¯è³ªçµã¿æãã¿ã€ã
æ¥å¹Žããæ°ããªæ²»éšãå§ãŸãâŠðš
ã
ã
mrna以å€ã®éžæè¢ãå¢ããã®ã¯è¯ãã
åœç£ã®ã¯ã¯ãã³ãšæãã®ã ã
ã¯ã¯ãã³ã ãã§ãªãæ²»çè¬ãã§ããŠã2é¡ãã5é¡ãžæ©ã移è¡ããŠæ¬²ãããã
ã¯ã¯ãã³ã ãã§ãªãæ²»çè¬ãã§ããŠã2é¡ãã5é¡ãžæ©ã移è¡ããŠæ¬²ãããã
è¡°éåœæ¥æ¬ãã¯ã¯ãã³ç¬ãå ãèš±ããããããïŒããèš±ããã!!ç«æ²æ°äž»å
å
񇜆
æ°äž»é£åæ¿åºæš¹ç«ããããã£ã³ã»ã«ããŠã·ãããã¯ãå°å
¥ããŠãããŠäžæ¥å奜ãã¹ãã§ãã
ãéçåãé²ãå¹æã¯100ïŒ
ãã£ãŠããããªãïŒãã
ãææ¥ãã¡ã€ã¶ãŒ1åç®
çµã¿æãã¿ã³ãã¯è³ªãããŒïŒãããåŸ
ã£ãŠãŸãããå¯äœçšå°ãªããã(åèŠïŒ
éºäŒåçµã¿æã
æ©ããã°ç§å£ãšèŠãã®ã§âŠå¹Žæãã§ããâïž
ããŒãð€å¹æåãããïŒåç®ã®ç©ºçœãåå®ã§ããðŠ
å¡©é矩ãæ¥æ¥ãšèããŠããã¯ããããã¯ã¹ã«çµã£ãŠããã®ã§âŠ
åé¡ã¯å¹æåãæ¥çš®è ã®ã»ããæªæ¥çš®è ããéçåãããšãã話(çåœã¯ãŸã äžç¢ºå®)
ããŒãð€å¹æåãããïŒåç®ã®ç©ºçœãåå®ã§ããðŠ
å¡©é矩ãæ¥æ¥ãšèããŠããã¯ããããã¯ã¹ã«çµã£ãŠããã®ã§âŠ
åé¡ã¯å¹æåãæ¥çš®è ã®ã»ããæªæ¥çš®è ããéçåãããšãã話(çåœã¯ãŸã äžç¢ºå®)
ïŒãããŸã§ã«ãBåèçã®ã¯ã¯ãã³ãªã©ã§çšããããŠãããäžæŽ»åã¯ã¯ãã³ã ããå±éºæ§ãå¯åå¿ã¯å°ãªãã
ãã£ãïŒãããªãæ¥çš®ããŠããããª( ^Ï^ )
ãã£ãïŒãããªãæ¥çš®ããŠããããª( ^Ï^ )
å¥åº·äœã«æ¥çš®ããŠãçèçãçºç±ãåŠæ æããã«ã¿æ ªããããã«å€ç°ããŠããã®ã«ãåšåº«æŽçã®æŠæŒ¢æ ªå¯Ÿå¿ã¯ã¯ãã³ãæ¥çš®ããŠãå¯èŸŒãã§ãããããããæããªãã®ãïŒ
ãã£ãšæãŠãã
è¯ãã£ãã
æ³£ããã
è¯ãã£ãã
æ³£ããã
ãªãã§æŠç°ã°ãããªãã ãããïŒãšãµãšæããã¢ãã«ããæŠç°ã ãã
亀差æ¥çš®ã«ã€ããŠãååŽçã®èŠè§£ãŸã ããªãã
NovavaxïŒæŠç°1å5000äžååãæ£åŒå¥çŽã
ååŽçããè¬ã¯ã©ããªã£ãã®ïŒ
ç«æ²å
±ç£æ¿æš©ã ã£ãããããããã¯ã¹è£œãããªããŠã·ãããã¯è£œã®å¥çŽã ã£ããããç«æ²å
±ç£æ¿æš©äžã§ã¯ããã€ãã³æ¿æš©ã®å£æ·»ãããªãããäœããäºæ¥ä»åãã§å
šå®åã«ãã£ãœåãããæªå€¢ã®ãããªæ°äž»å
æ¿æš©åæ§ãåçå®åãã¡ãããšåããªããããªã
ð±ãŸãã«ã¯ã¯ãã³ããããæ¢å®è·¯ç·ã
é£ç©ã¢ã¬ã«ã®ãŒã§ã¢ããã£ã©ãã·ãŒã·ã§ãã¯çµéšããŠããããã©ãããŠãäžå®ãæããã¯ã¯ãã³æªæ¥çš®ã ãã©ããããªãæ¥çš®ããŠãè¯ããªâŠâ
æåœãã次第ã®ã¯ã¯ãã³æ¥çš®åŒ·èŠã
ããã¯ããªãå±éºãªç¶æ³ã
æ¿æš©äº€ä»£ããªããã°ãããå±ãªãæ¡ä»¶ã
ããã¯ããªãå±éºãªç¶æ³ã
æ¿æš©äº€ä»£ããªããã°ãããå±ãªãæ¡ä»¶ã
ãªãããã¥ãŒã«ããŒããããããã
äœã«äœ¿ãã®ïŒ
確ãäžã®äººããå€ç°æ ªå¯Ÿå¿ããã§ããããŒãã£ãŠèšã£ãŠãã®èªãã ãã©ããã«ã·ãããªããšãããªã
ããŠããŠå¹æã¯ããã«âŠïŒ
3åç®ã®ããŒã¹ã¿ãŒæ¥çš®ãèŠéã«å
¥ãããšãªããšã次ã®ã²ãŒã ãã§ã³ãžã£ãŒã¯ããã ãã
çããåŸ æã®ãåœç£ãã§ãã
çããåŸ æã®ãåœç£ãã§ãã
ã·ãããã¯ã«ç©ºç®ïŒç¬ïŒ
ã©ããªãã ãããïŒãã£ã¡ãäžåç®ã§ããŠãã®ãïŒå®å
šãªã®ãïŒãã¡ã€ã¶ãŒã¢ãã«ãé¿ããã人ã¯ãã£ã¡ããã€ã¹ããªã®ã ãããïŒ
åœç¶ãNovavaxã®ã¯ã¯ãã³ã3åç®ã®ããŒã¹ã¿ãŒãšããŠäœ¿ããªããããšèšãçŽ æŽãªçåã¯åºãŠããããã§ã
幎äžåãSARS-CoV-2ïŒã€ã³ãã«ãšã³ã¶ã®çµã¿æãã¿ã³ãã¯ã¯ã¯ãã³ãæã€ãšèšãäºãå°æ¥ã®äºæ³ãšããŠã¯åºãŠããŸãã
ã©ããªãããšããã
幎äžåãSARS-CoV-2ïŒã€ã³ãã«ãšã³ã¶ã®çµã¿æãã¿ã³ãã¯ã¯ã¯ãã³ãæã€ãšèšãäºãå°æ¥ã®äºæ³ãšããŠã¯åºãŠããŸãã
ã©ããªãããšããã
æ°ããã¯ã¯ãã³ã ïŒ
åãŠã€ã«ã¹å¢ãã¯ãªãšã€ãã£ããã£ãçºæ®ãããã£ã³ã¹ãå°æ¥ãããïŒ
殺ãããã奎é·åã®æ¬¡ã¯ãªãã ïŒïŒ
ããã¯5Gã«ç¹«ããã®ãïŒ
å¹æãå°ãäœããã4GããªïŒ
åãŠã€ã«ã¹å¢ãã¯ãªãšã€ãã£ããã£ãçºæ®ãããã£ã³ã¹ãå°æ¥ãããïŒ
殺ãããã奎é·åã®æ¬¡ã¯ãªãã ïŒïŒ
ããã¯5Gã«ç¹«ããã®ãïŒ
å¹æãå°ãäœããã4GããªïŒ
次ã¯ããããã¯ã¹è£œåã ããã¢ã¡ãªã«è£œã ãã
ãã¡ã€ã¶ãŒ1.94åãã¢ãã«ã1åãã¢ã¹ãã©1.2åã
ããã«å ããŠãä»åã®ããããã¯ã¹1.5å
3åç®æºåããŠãŸããããã
ããã«å ããŠãä»åã®ããããã¯ã¹1.5å
3åç®æºåããŠãŸããããã
ååééããŠã·ãããã¯èŒžå
¥ãããšããŠãª
ä»ææ«ã«ïŒåç®ã®æ¥çš®ã ãã
äžåºŠè¯ãæãã